Rankings · Dividends
A-graded dividend payers
Graded A and paying a regular dividend yielding at least 1%, ranked by size rather than by yield. The highest yields usually belong to the companies under the most strain, so a list opening on them would mislead.
14 companies meet this test
Figures as of November 15, 2026
| # | Company | Grade | Market value | Dividend yield | Years of rises | Payout ratio |
|---|---|---|---|---|---|---|
| 1 | JNJJohnson & Johnson | A+ | $687.9B | 1.8% | 9+ years | 80% |
| 2 | MRKMerck & Co., Inc. | A | $364.3B | 2.3% | 9+ years | 347% |
| 3 | NVSNovartis AG | A | $306.3B | 1.9% | 6 years | 43% |
| 4 | AMGNAmgen Inc. | A+ | $251.9B | 2.1% | 9+ years | 58% |
| 5 | GILDGILEAD SCIENCES, INC. | A | $208.5B | 1.9% | 9+ years | — |
| 6 | MDTMedtronic plc | A+ | $131.6B | 2.3% | 1 year | 57% |
| 7 | SYKSTRYKER CORP | A+ | $117.9B | 1.1% | 6 years | 37% |
| 8 | CVSCVS HEALTH Corp | A | $114.3B | 3.0% | 0 years | 31% |
| 9 | GSKGSK plc | A+ | $108.9B | 3.5% | 2 years | 48% |
| 10 | CIThe Cigna Group | A | $78.3B | 2.1% | 5 years | 27% |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.